Chinese Journal of Contemporary Neurology and Neurosurgery ›› 2024, Vol. 24 ›› Issue (1): 39-43. doi: 10.3969/j.issn.1672-6731.2024.01.008

• Synchronous Surgical Treatment for Brain and Heart • Previous Articles     Next Articles

Cerebral embolic protection during transcatheter aortic valve replacement

Shao-peng ZHANG, Yun-peng BAI, Nan JIANG*()   

  1. Department of Cardiovascular Surgery, Tianjin Institute of Cardiovascular Disease; Tianjin Key Laboratory of Cardiovascular Emergency and Critical Care, Chest Hospital, Tianjin University, Tianjin 300222, China
  • Received:2023-11-16 Online:2024-01-25 Published:2024-01-30
  • Contact: Nan JIANG
  • Supported by:
    Tianjin Key Medical Discipline (Specialty) Construction Project(TJYXZDXK-042A); Tianjin Applied Basic Research Key Project(22JCYBJC01430)

经导管主动脉瓣置换术中的脑保护

张韶鹏, 白云鹏, 姜楠*()   

  1. 300222 天津大学胸科医院心血管外科 天津市心血管病研究所 天津市心血管急危重症重点实验室
  • 通讯作者: 姜楠
  • 基金资助:
    天津市医学重点学科(专科)建设项目(TJYXZDXK-042A); 天津市应用基础研究重点项目(22JCYBJC01430)

Abstract:

After more than 20 years of development, the complications of transcatheter aortic valve replacement (TAVR) have been significantly reduced, but the incidence of stroke has not been significantly reduced. In recent years, a variety of cerebral embolic protection device (CEPD) have been applied in clinical practice, but their effectiveness is still controversial due to the lack of high-quality clinical evidence. This article reviews progress on the risk factors for stroke and the characteristics of intraoperative CEPD in TAVR, so as to provide reference for the selection of TAVR cases and the formulation of cerebral embolic protection strategies.

Key words: Transcatheter aortic valve replacement, Embolic protection devices, Postoperative complications, Stroke, Review

摘要:

经导管主动脉瓣置换术经过20余年的发展,手术相关并发症已明显减少,唯术后脑卒中发生率无明显降低。近年多种脑保护装置应用于临床,但因缺乏高质量循环医学证据支持,其有效性尚存较大争议。本文综述经导管主动脉瓣置换术相关脑卒中危险因素以及术中脑保护装置的应用,为病例选择和脑保护策略制定提供参考。

关键词: 经导管主动脉瓣置换, 栓塞保护装置, 手术后并发症, 卒中, 综述